Smoking and autoimmune thyroid disease: the plot thickens

被引:38
作者
Krassas, GE
Wiersinga, W
机构
[1] Panagia Gen Hosp, Dept Diabet Endocrinol & Metab, Thessaloniki 54622, Greece
[2] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1012 WX Amsterdam, Netherlands
关键词
D O I
10.1530/eje.1.02157
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New studies have shown that smoking may protect against the development of thyroid peroxidase antibodies, which may result in a decreased risk of Hashimoto's hypothyroidism (HH). whereas it stimulates the development of Graves hyperthyroidism (GH). According to the above-mentioned hypothesis, to stop smoking would decrease the risk of GH but increase the risk of HH. Also. smoking has been identified as one of the risk factors for the development or worsening of eye changes after I-131 treatment of GH. Additionally the outcome of medical treatment of Graves' ophthalmopathy (GO) is less favourable in smokers as compared to non-smokers. There is concern also about the effect of passive smoking on autoimmune thyroid disease. In a recent study it has been shown that the latter may have it deleterious effect on childhood GO.
引用
收藏
页码:777 / 780
页数:4
相关论文
共 16 条
[1]   Cigarette smoking and treatment outcomes in Graves ophthalmopathy [J].
Bartalena, L ;
Marcocci, C ;
Tanda, ML ;
Manetti, L ;
Dell'Unto, E ;
Bartolomei, MP ;
Nardi, M ;
Martino, E ;
Pinchera, A .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (08) :632-635
[2]   Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third national health and nutrition examination survey (NHANES III) [J].
Belin, RM ;
Astor, BC ;
Powe, NR ;
Ladenson, PW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12) :6077-6086
[3]   Impact of smoking on the response to treatment of thyroid associated ophthalmopathy [J].
Eckstein, A ;
Quadbeck, B ;
Mueller, G ;
Rettenmeier, AW ;
Hoermann, R ;
Mann, K ;
Steuhl, P ;
Esser, J .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (06) :773-776
[4]   Effects of L-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study [J].
Glinoer, D ;
de Nayer, P ;
Bex, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (05) :475-483
[5]   Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease [J].
Goh, SY ;
Ho, SC ;
Seah, LL ;
Fong, KS ;
Khoo, DHC .
CLINICAL ENDOCRINOLOGY, 2004, 60 (05) :600-607
[6]   Relapse of Graves' disease after successful outcome of antithyroid drug therapy: Results of a prospective randomized study on the use of levothyroxine [J].
Hoermann, R ;
Quadbeck, B ;
Roggenbuck, U ;
Szabolcs, I ;
Pfeilschifter, J ;
Meng, W ;
Reschke, K ;
Hackenberg, K ;
Dettmann, J ;
Prehn, B ;
Hirche, H ;
Mann, K .
THYROID, 2002, 12 (12) :1119-1128
[7]   Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism [J].
Holm, IA ;
Manson, JE ;
Michels, KB ;
Alexander, EK ;
Willett, WC ;
Utiger, RD .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (14) :1606-1611
[8]   Does smoking increase relapse rates in Graves' disease? [J].
Kimball, LE ;
Kulinskaya, E ;
Brown, B ;
Johnston, C ;
Farid, NR .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (02) :152-157
[9]   High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study [J].
Knudsen, N ;
Bülow, I ;
Laurberg, P ;
Perrild, H ;
Ovesen, L ;
Jorgensen, T .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (03) :571-576
[10]   Childhood Graves' ophthalmopathy: results of a European questionnaire study [J].
Krassas, GE ;
Segni, M ;
Wiersinga, WM .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (04) :515-520